Indoco Remedies arm launches heart attack drug Ticagrelor filmcoated in UK

Mumbai: Indoco Remedies has announced that its subsidiary company, Indoco Remedies UK Limited, has officially launched Ticagrelor film-coated tablets 90mg in the United Kingdom.

This significant addition to Indoco’s portfolio will be marketed and distributed by Clarity Pharma, across the United Kingdom.

Ticagrelor film-coated tablets are indicated to reduce the chances of heart attack, stroke, myocardial infarction (MI) or diseases related to the heart or blood vessels.

“This development underscores our commitment to bringing high quality, life-saving treatments to patients in the UK”, said Aditi Kare Panandikar, Managing Director, Indoco Remedies Ltd.

Read also: Indoco Remedies Varenicline Tablets gets USFDA nod to aid smoking cessation treatment

Indoco is a fully integrated, research-oriented pharmaceutical company with a global presence. The Company’s turnover is US$ 180 million with a human capital of over 6000 employees, including over 400 skilled scientists and field staff. The Company has 11 manufacturing facilities, 7 for FDFs and 4 for APIs, supported by a state-of-the-art R&D Centre and a CRO facility. The facilities have been approved by most of the Regulatory Authorities including USFDA and UK-MHRA. Indoco develops and manufactures a wide range of pharmaceutical products for the Indian and international markets. It generates more than 106 million prescriptions annually from over 2,40,000 doctors belonging to various specialties.